REGCP vs TECH · rev $1.55B vs P/E 65, rev $1.22B
Regency Centers Corporation 6.25% Series A Cumulative Redeemable Preferred Stock (REGCP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation 6.25% Series A Cumulative Redeemable Preferred Stock (REGCP) is a reit - retail company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported REGCP revenue for 2025-12-31 was $1.55B. Net income was $527.5M. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. REGCP currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
REGCP currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the REGCP and TECH stock pages for the full models.
Not investment advice.